Rchr
J-GLOBAL ID：201801015816250361
Update date: Apr. 10, 2024
Kato Ken
カトウ ケン | Kato Ken
Affiliation and department：
Job title：
Chief of Department of Head and Neck, Esophageal Medical Oncology/Gastrointestinal Medical Oncology
Research field (1)：
Tumor diagnostics and therapeutics
Research theme for competitive and other funds (1)：
- 2011 - 2014 Mechanistic analysis and prediction of infusion reactions
Papers (261)：
-
Shota Igaue, Ryoko Nozaki, Daichi Utsunomiya, Yuto Kubo, Kentaro Kubo, Daisuke Kurita, Shun Yamamoto, Koshiro Ishiyama, Junya Oguma, Ken Kato, et al. Significance of Surgery for Resectable M1 Lymph Node Metastases Without Organ Metastasis in Esophageal Carcinoma in the Era of Neoadjuvant Treatment. Annals of surgical oncology. 2024. 31. 3. 1525-1535
-
Keita Sasaki, Motoo Nomura, Ken Kato, Katsuyuki Sakanaka, Yoshinori Ito, Tomohiro Kadota, Ryunosuke Machida, Tomoko Kataoka, Keiko Minashi, Yasuhiro Tsubosa, et al. A phase III randomized controlled trial comparing local field with additional prophylactic irradiation in chemoradiotherapy for clinical-T1bN0M0 esophageal cancer: ARMADILLO trial (JCOG1904). Japanese journal of clinical oncology. 2024. 54. 1. 103-107
-
Ryosuke Kita, Yoshitomo Yanagimoto, Hiroshi Imazeki, Eisuke Booka, Takahiro Tsushima, Junki Mizusawa, Keita Sasaki, Haruhiko Fukuda, Yukinori Kurokawa, Hiroya Takeuchi, et al. Protocol digest of a randomized controlled adaptive Phase II/III trial of neoadjuvant chemotherapy for Japanese patients with oesophagogastric junction adenocarcinoma: Japan Clinical Oncology Group Study JCOG2203 (NEO-JPEG). Japanese journal of clinical oncology. 2023
-
Hiroki Osumi, Atsuo Takashima, Akira Ooki, Yuri Yoshinari, Takeru Wakatsuki, Hidekazu Hirano, Izuma Nakayama, Natsuko Okita, Ryoichi Sawada, Kota Ouchi, et al. A multi-institutional observational study evaluating the incidence and the clinicopathological characteristics of NeoRAS wild-type metastatic colorectal cancer. Translational oncology. 2023. 35. 101718-101718
-
Shigeru Tsunoda, Yasuhiro Tsubosa, Keita Sasaki, Ryunosuke Machida, Ryosuke Kita, Haruhiko Fukuda, Kazuo Koyanagi, Hiroya Takeuchi, Takashi Kamei, Shinji Mine, et al. A multicenter randomized controlled trial of esophagectomy with or without prophylactic supraclavicular node dissection: a phase 3 trial (JCOG2013, MODERN3). JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 2023. 53. 9. 858-862
ｍore...
MISC (114)：
-
Motoo Nomura, Katsuyuki Sakanaka, Ken Kato, Tomohiro Kadota, Yoshinori Ito, Ryunosuke Machida, Keita Sasaki, Tomoko Kataoka, Yasumasa Nishimura, Yuko Kitagawa. A randomized controlled phase III trial of comparing local field with additional prophylactic irradiation in chemoradiotherapy for clinical-T1bN0M0 esophageal cancer:JCOG1904/ARMADILLO study. JOURNAL OF CLINICAL ONCOLOGY. 2021. 39. 3
-
Seiichiro Mitani, Ken Kato, Hiroyuki Daiko, Isao Nozaki, Takashi Kojima, Masahiko Yano, Satoru Nakagawa, Masaki Ueno, Masaya Watanabe, Shigeru Tsunoda, et al. Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: Supplementary analysis of the JCOG trial, JCOG0502. JOURNAL OF CLINICAL ONCOLOGY. 2020. 38. 15
-
Tomoya Yokota, Ken Kato, Yasuo Hamamoto, Yasuhiro Tsubosa, Hirofumi Ogawa, Yoshinori Ito, Hiroki Hara, Takashi Ura, Takashi Kojima, Keisho Chin, et al. A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer. Annals of surgical oncology. 2020. 27. 2. 460-467
-
Ken Kato, Byoung Chul Cho, Masanobu Takahashi, Morihito Okada, Chen-Yuan Lin, Keisho Chin, Shigenori Kadowaki, Myung-Ju Ahn, Yasuo Hamamoto, Yuichiro Doki, et al. Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial. The Lancet. Oncology. 2019. 20. 11. 1506-1517
-
野村 基雄, 清水 充子, 大橋 真也, 三梨 桂子, 加藤 健, 小島 隆嗣, 坂中 克行, 武藤 学. 食道癌に対する根治的CRTとNivolumab併用による医師主導治験 Trial in progress. 日本癌治療学会学術集会抄録集. 2019. 57回. P9-5
ｍore...
Books (1)：
-
術前化学療法と術前化学放射線療法は,効果・安全性の面からどちらが良いか?
医事新報社 2017
Lectures and oral presentations (1)：
-
A randomized controlled phase III comparing CF (5-FU, CDDP) versus DCF (5-FU, CDDP, docetaxel) versus CF-RT as neoadjuvant treatment for locally advanced esophageal cancer
(International Symposium of Disease of Esophagus 2018)
Return to Previous Page
